Price change (24h):
0.22%
High (24h):
$0.03093978
Low (24h):
$0.02905058
Volume (24h):
$21.46M
Market Cap:
$62.84M
All Time High:
96.68% $0.89
Jan 3, 2025
All Time Low:
86% $0.02
Mar 29, 2026
42.50 %(1Y)
$0.02929896
Price change (24h):
0.22%
High (24h):
$0.03093978
Low (24h):
$0.02905058
Volume (24h):
$21.46M
Market Cap:
$62.84M
All Time High:
96.68% $0.89
Jan 3, 2025
All Time Low:
86% $0.02
Mar 29, 2026
Bio Protocol (BIO) is a cryptocurrency launched in 2025. It operates as a curation and liquidity layer for Decentralized Science (DeSci), directly connecting patient, researcher, and investor communities with tokenized biotechnology assets.
The protocol targets the structural inefficiency of early-stage biomedical funding—a domain where traditional venture capital routinely bypasses high-risk longevity science and rare disease research. Communities use the platform to collectively fund and govern tokenized biotech intellectual property, transforming passive capital allocators into active stakeholders in drug development pipelines. This model compresses the decades-long translational gap between lab discovery and clinical trial.
Bio Protocol operates on the Ethereum network. Token contracts exist natively on Solana, BNB Chain, and Base, embedding the asset into multiple high-liquidity environments simultaneously. Such multi-chain architecture helps circumvent isolated liquidity silos that often fragment niche scientific tokens.
The token adheres to the ERC-20 standard on Ethereum, with bridged representations on the other integrated networks. All contract addresses are publicly verifiable through Etherscan, Solscan, and BscScan. This cross-chain deployment avoids relying on any single chain’s security model while maintaining full auditability for community oversight.
The project’s origins trace to Molecule, a tokenization framework for early-stage biomedicine, and VitaDAO, the world’s largest decentralized longevity research collective. The core contributors launched BIO in January 2025 as a dedicated financial layer to scale those precursor experiments into a full economic flywheel for onchain scientific commercialization.
The protocol’s long-term purpose is to unbundle institution-dominated biomedical funding and reassemble it as a globally accessible, community-owned public good. Rather than relying on patent-heavy pharma incumbents, BIO seeks to turn intellectual property into liquid, composable digital assets that patient communities and researchers govern directly.
Token holders use BIO to stake into curation pools that signal which sub-communities or specific IP tokens deserve funding priority. The token also acts as a membership instrument, granting admission to specialized DeSci DAOs, and as a settlement asset for liquidity provision across tokenized biotech portfolios. These mechanical functions calibrate participant incentives without centralized intermediaries.
Researchers and patient advocacy groups acquire BIO to launch new biotech-focused DAOs and propose funding rounds. Liquidity providers deposit BIO into automated market making pools tied to tokenized IP, capturing trading fees and protocol emissions. Holding the asset gives exposure to a diversified basket of early-stage biomedical projects without requiring direct company stock.
Bio Protocol has a maximum supply of 3,320,000,000 tokens. Currently, 1,769,745,956.34 are in circulation. With a market capitalization of $53,963,851, Bio Protocol ranks #455 among all cryptocurrencies.
| Date | Open | Close | High | Low |
|---|---|---|---|---|
| 07/07/2026 | $0.03 | $0.03 | $0.03 | $0.03 |
| 06/07/2026 | $0.03 | $0.03 | $0.03 | $0.03 |
| 05/07/2026 | $0.03 | $0.03 | $0.03 | $0.03 |
| 04/07/2026 | $0.03 | $0.03 | $0.03 | $0.03 |
| 03/07/2026 | $0.03 | $0.03 | $0.03 | $0.03 |
| 02/07/2026 | $0.03 | $0.03 | $0.03 | $0.03 |
| 01/07/2026 | $0.03 | $0.03 | $0.03 | $0.03 |
| 30/06/2026 | $0.03 | $0.03 | $0.03 | $0.03 |
AI trades 24/7 automatically Catch every opportunity
Zero-emotion algorithm Disciplined strategy
Passive income Set & forget automation
20,000+
traders trusted Stoic AI
$200M+
in cumulative assets under management since inception
2015
year of company foundation
Disclaimer:
This website is operated by Cindicator Ltd. (“Cindicator”), a Gibraltar private company. You are solely responsible for compliance with all laws that may apply to you and your use of Cindicator products. Cryptocurrencies and blockchain technologies have been the subject of scrutiny by regulatory bodies worldwide. With respect to your use of Cindicator products, Cindicator makes no representations regarding the applicability or compliance of its products with any laws or regulations, including, without limitation, those related to trading, options, derivatives, or securities. You also assume all legal, economic, and other risks related to your use of Cindicator products, including legal uncertainty, market volatility, and information security risks, among others. Trading in cryptocurrencies and digital assets is highly speculative, and the value of investments can fluctuate dramatically. You may lose a substantial portion or even all of your invested capital, and such trading may not be suitable for everyone. If you are unsure about these risks or your ability to bear potential losses, you should consult with an independent financial advisor before using Cindicator products. Depending on your jurisdiction, access to or use of Cindicator products may be subject to certain legal restrictions or prohibitions. You agree that it is solely your responsibility to determine and comply with any laws and regulations applicable to your use of Cindicator products, and that Cindicator is not responsible for informing you of such requirements.
Cindicator reserves the right to restrict or refuse access to its products for citizens or residents of certain jurisdictions, including those subject to international sanctions or other legal restrictions. All materials provided on this website (including any graphical materials regarding trading strategy performance or P&L) are presented solely for marketing and informational purposes. They do not guarantee any future profits and should not be construed as financial, investment, legal, or other professional advice. Cindicator is not a registered broker-dealer, investment adviser, or regulated financial institution, and the information and services provided do not constitute personal investment advice or a recommendation or offer to buy or sell any securities, cryptocurrencies, or other financial instruments. The information provided herein is summary in nature, does not purport to be complete, and is provided “as is” without any warranty as to its accuracy or completeness. All content may be updated or changed at any time without notice. Past performance is not indicative of future results. To the maximum extent permitted by law, Cindicator (including its directors, officers, and affiliates) shall not be liable for any loss or damage (direct, indirect, special, consequential, or incidental) arising from your use of Cindicator products, this website, or any information contained herein. Please read our Terms of Use for further details. If you do not agree with these terms, please close this site.